Recent Headlines
Within Biopharmaceuticals & Biotherapeutics

AnaSpec Offers Custom Synthesis of Hydrocarbon-Stapled Peptides

The innovative technique of hydrocarbon stapling in peptides is introducing valuable new functionality to peptide-related research. AnaSpec is pleased to offer custom synthesis for hydrocarbon-stapled peptides. Hydrocarbon-stapled peptides are peptides capable of forming stable alpha helical... - June 20, 2008 - AnaSpec, EGT Group

Anavex Further Strengthens Board of Directors

Anavex Life Sciences Corp. ("Anavex") (OTCBB: AVXL) today announced the appointment of David L. Tousley, CPA, MBA, to its Board of Directors. Mr. Tousley is an accomplished professional with many years of experience as a senior financial and operations executive in start-up and... - June 20, 2008 - Anavex Life Sciences Corp.

New Anti-CARMA Antibody Series Released by AnaSpec

AnaSpec has introduced a new series of IHC validated antibodies, Anti-CARMA/CARD/Bimp antibodies. CARMA proteins are scaffold molecules that belong to the membrane-associated guanylate kinase-like (MAGUK) and the caspase-associated recruitment domain (CARD) protein families. They play critical... - June 19, 2008 - AnaSpec, EGT Group

AnaSpec Introduces Eleven New Peptides

This week AnaSpec, a world leader in custom and catalog peptides, introduced eleven (11) new peptides. - June 18, 2008 - AnaSpec, EGT Group

New SensoLyte™ 520 Cathepsin S Assay Kit Introduced by AnaSpec

AnaSpec has introduced the SensoLyte™ 520 Cathepsin S Assay Kit to its broad collection of long wavelength FRET protease assay kits. - May 29, 2008 - AnaSpec, EGT Group

AnaSpec Introduces Sixty New Peptides & 3 New Assay Kits

This week, AnaSpec introduced sixty (60) new catalog peptides and three (3) new assay kits. - May 27, 2008 - AnaSpec, EGT Group

AnaSpec Introduces 8 New Antibody Products

AnaSpec added eight (8) new antibody products to its growing collection. - May 24, 2008 - AnaSpec, EGT Group

Anavex Announces Appointment of Oncology Specialist to Board of Directors, Changes to Executive Management

Anavex Life Sciences Corp. ("ANAVEX'') (OTC BB:AVXL.OB) today announced the appointment of Alison Ayers to its Board of Directors. Ms. Ayers is currently the Worldwide Commercial Head for Oncology at Pfizer, with responsibility for Pfizer's oncology portfolio, which includes more than 20 drug... - May 23, 2008 - Anavex Life Sciences Corp.

AnaSpec Introduces ClearPoint™ Heavy Isotope-Labeled Peptides

AnaSpec has introduced ClearPoint™ Peptides, heavy isotope-labeled peptides for absolute quantitation (AQUA) of proteins. - May 18, 2008 - AnaSpec, EGT Group

AnaSpec’s Published References Passes 600

The number of published papers that cite AnaSpec’s products has passed 600. - May 04, 2008 - AnaSpec, EGT Group

AnaSpec Presents Fluorimetric TACE Detection Poster at SBS Conference

AnaSpec presented its latest findings in regards to the detection of TACE activity using FRET technology. - May 03, 2008 - AnaSpec, EGT Group

AnaSpec Introduces a Suite of Phospho-Specific Anti-Her2 Antibodies

AnaSpec has introduced a full suite of phospho-specific ErbB-2 (Her-2) polyclonal antibodies. - April 30, 2008 - AnaSpec, EGT Group

AnaSpec Introduces 13 New Antibody Products

AnaSpec added thirteen (13) new antibody products to its growing collection. - April 25, 2008 - AnaSpec, EGT Group

SensoLyte™ MMP Assay Kits Offer a New Industry Standard for Sensitivity

AnaSpec’s SensoLyte™ line of MMP assay kits have quickly become the new standard in MMP assay sensitivity. - April 24, 2008 - AnaSpec, EGT Group

AnaSpec FRET-Based MMP Substrates Used in Double Differential in Vivo Zymography

AnaSpec FRET-based MMP substrates were recently used in a double differential in vivo zymography study at the University of New Brunswick. - April 23, 2008 - AnaSpec, EGT Group

New Anti-MMP Antibodies Introduced by AnaSpec

AnaSpec has introduced its newest MMP antibodies. - April 11, 2008 - AnaSpec, EGT Group

AnaSpec Offers Fluo-3 - a High Affinity Fluorescent Calcium Indicator

Calcium plays a vital role in the specific and selective regulation of major cellular processes and is central in the regulation of cardiac contractility, growth and gene expression. Calcium indicators are small molecules that can respond to the binding of Ca2+ ions by changing their spectral... - March 29, 2008 - AnaSpec, EGT Group

Avanti Therapeutics Launches Chikujee Therapeutics, a Targeted Drug Delivery Company

Avanti Therapeutics, a privately held biopharmaceutical company, said it has incubated and launched a new bionanotechnology company for targeted drug delivery called Chikujee Therapeutics. Chikujee Therapeutics hopes to commercialize nanomedicines using its proprietary, cell specific targeted drug... - March 28, 2008 - Chikujee Therapeutics

AnaSpec Introduces Suite of Labeled & Unlabeled Anti-Actin Antibodies

AnaSpec has introduced a suite of labeled and unlabeled anti-Actin antibodies. - March 26, 2008 - AnaSpec, EGT Group

AnaSpec Introduces New Technical Support Solution

This month AnaSpec introduced a significantly improved online technical support resource for its website users. AnaSpec's new Frequently Asked Questions (FAQ) Page now offers a searchable database of solutions that offers a more convenient and more comprehensive solution for technical support needs. - March 22, 2008 - AnaSpec, EGT Group

AnaSpec Introduces Phosphopeptide Standards Kit

AnaSpec has introduced a dependable tool for the analysis and characterization of phosphorylated peptides – AnaSpec’s Phosphopeptide Standards Kit. - March 19, 2008 - AnaSpec, EGT Group

Biopharma Innovators Syntaxin Wins Top Honours at 2007 Interactive Media Awards

Biopharma firm Syntaxin's new website has won a very prestigious IMA award which recognises great design, technical innovation and accessibility compliance within the interactive media industry. - March 19, 2008 - Syntaxin Ltd

AnaSpec Introduces 58 New Antibody Products

Continuing to rapidly expand its antibody offerings, AnaSpec has added fifty-eight (58) new antibody products to its growing collection. Anti-PTEN (pSer385) (polyclonal) - Cat# 29642-025, 25 µg Host: rabbit polyclonal; Species Reactivity: human; rat; mouse; Applications: IP; WB;... - March 16, 2008 - AnaSpec, EGT Group

AnaSpec Introduces New SensoLyte™ Cathepsin D Activity Assay Kits

AnaSpec has introduced a new series of SensoLyte™ Cathepsin D Activity Assay Kits to address the issue of autofluorescence interference. - March 09, 2008 - AnaSpec, EGT Group

AnaSpec Introduces Two Novel Amino Acids

AnaSpec has introduced two novel amino acids that offer additional tools and functionality for peptide chemists. - March 05, 2008 - AnaSpec, EGT Group

AnaSpec Introduces 9 New Antibody Products

AnaSpec added nine new antibody products to its growing collection. - February 28, 2008 - AnaSpec, EGT Group

AnaSpec Introduces 5 New Peptide Synthesis Reagents

AnaSpec added five (5) new peptide synthesis reagents to its combinatorial chemistry collection. - February 24, 2008 - AnaSpec, EGT Group

AnaSpec Introduces Collection of Channel Blocker Peptides

AnaSpec has introduced its selection of channel blocker peptides. - February 21, 2008 - AnaSpec, EGT Group

AnaSpec Introduces New Suite of Fluorescently Labeled GST & 6xHis Tag Antibodies

AnaSpec has introduced a suite of fluorescently labeled GST and 6X-His antibodies. These antibodies are labeled with a selection of dyes, including AnaSpec’s proprietary HiLyte FluorTM and HiLytePlusTM dyes, which span the visible spectrum. This gives researchers a wide range of wavelength... - February 16, 2008 - AnaSpec, EGT Group

AnaSpec Introduces 46 New Antibody Products

Continuing to rapidly expand its antibody offerings, AnaSpec added forty-six (46) new antibody products to its growing collection. Anti - GST Tag AMCA labeled - Cat# 29531-AMCA, 100 µg Host: mouse monoclonal; Application: IHC Anti - GST Tag Biotin labeled - Cat# 29531-BIOT, 100... - February 13, 2008 - AnaSpec, EGT Group

AnaSpec Introduces 21 New Anti-Tau Antibodies

AnaSpec has announced the release of 21 new anti-Tau antibodies. Complementing one of the world’s most comprehensive collections of beta-amyloid peptides, this new selection of anti-Tau antibodies demonstrates AnaSpec’s efforts to deliver new solutions for Alzheimer research. Tau is a... - February 11, 2008 - AnaSpec, EGT Group

AnaSpec Introduces 9 New Antibody Products

Continuing to rapidly expand its antibody offerings, AnaSpec added nine (9) new antibody products to its growing collection. Anti-AKT pan (IN) - Cat# 54320, 50 µg Host: rabbit polyclonal; Species Reactivity: human; mouse; rat; bovine; zebrafish; Applications: WB Anti-AKT pan (NT) - Cat#... - January 27, 2008 - AnaSpec, EGT Group

Anavex Outlines Corporate Milestones, Drug Advancement Plans for 2008

Anavex Life Sciences Corp. achieved significant development of its lead drug candidates and growth of its management and scientific teams during 2007. - January 24, 2008 - Anavex Life Sciences Corp.

AnaSpec Announces a Broad Selection of T-Cell Epitopes

AnaSpec has announced the availability of a wide selection of T-Cell Epitopes, available both individually and pooled. - January 23, 2008 - AnaSpec, EGT Group

Anavex Advances Drug Candidate for Treatment of Alzheimer's Disease

Results from animal model testing demonstrate ANAVEX 1-41 has significant neuroprotective and anti-amnesic benefits. - January 16, 2008 - Anavex Life Sciences Corp.

Anavex 7-1037 Demonstrates Chemotherapeutic Potential Without Toxic Side Effects for the Treatment of Colorectal Cancer, Other Types of Solid Tumors

ANAVEX 7-1037 has been shown to kill human HCT116 colon cancer cells in advanced pre-clinical studies. - January 16, 2008 - Anavex Life Sciences Corp.

Anavex Strengthens Board of Directors

Anavex Life Sciences Corp. ("ANAVEX") (OTCBB: AVXL - News) announces the appointment of Dr. Cameron Durrant to its Board of Directors. - January 16, 2008 - Anavex Life Sciences Corp.

AnaSpec Introduces Ten New Catalog Peptides

This week AnaSpec, one of the world’s largest providers of custom and catalog peptides, introduced ten (10) new catalog peptides and one new unusual amino acid. MSL8; [Met256]-OVA (257-264)- Cat# 62573-5 Sequence: MSIINFEKL MSL8; [Met256]-OVA (257-264)- Cat# 62573-1 Sequence: MSIINFEKL OVA... - January 04, 2008 - AnaSpec, EGT Group

AnaSpec Introduces Sixteen New Catalog Peptides

This week AnaSpec, one of the world’s largest providers of custom and catalog peptides, introduced sixteen (16) new catalog peptides. [Cys17]-beta-Amyloid (1-17)- Cat# 62473 This peptide amino acids 1 to 17 is a modified fragment of the b-amyloid peptide; with cysteine substituted for valine... - December 20, 2007 - AnaSpec, EGT Group

AnaSpec Introduces First Colorimetric SensoLyte™ MMP Assay Kit

AnaSpec has introduced its first quantitative and homogeneous colorimetric MMP assay kit. - December 19, 2007 - AnaSpec, EGT Group

AnaSpec Introduces New Selection of Dye-Labeled Beta-Amyloid Peptides

AnaSpec introduces a new line of labeled amyloid peptides. - December 16, 2007 - AnaSpec, EGT Group

AnaSpec Introduces 10 New Catalog Antibodies

Continuing to rapidly expand its antibody offerings, AnaSpec added ten (10) new catalog antibodies to its growing collection. Anti-ATF2 (pT69/71) - Cat# 54323, 50 µg/250 µl Host: rabbit polyclonal; Species Reactivity: Human; Mouse; Rat; Zebrafish; Bovine; Applications: WB Anti-ATF2... - December 15, 2007 - AnaSpec, EGT Group

AnaSpec Releases New Antibodies Brochure

With a collection that has been rapidly expanded in the last few years, AnaSpec has organized its growing selection of antibodies into its newest antibodies brochure. The brochure showcases: • Primary antibodies • HRP, AP and biotin conjugated secondary antibodies • Patented... - December 14, 2007 - AnaSpec, EGT Group

AnaSpec Introduces Eight New Catalog Peptides and One Unusual Amino Acid

This week AnaSpec, one of the world’s largest providers of custom and catalog peptides, introduced eight (8) new catalog peptides and one new unusual amino acid. - December 07, 2007 - AnaSpec, EGT Group

AnaSpec Introduces New Collection of Bcl Peptides

AnaSpec introduced a collection of peptides related to the family of proteins called Bcl-2 (B-cell lymphoma 2) for use in cancer research or cell cycle research. - December 06, 2007 - AnaSpec, EGT Group

AnaSpec Introduces 17 New Anti-Tau Antibodies

Continuing to rapidly expand its antibody offerings, AnaSpec added seventeen (17) new anti-Tau antibodies to its growing collection. Anti-Tau (paired181) - Cat# 54961, 50 µg Host: rabbit polyclonal; Species Reactivity: Human; Mouse; Rat; Applications: WB Anti-Tau (paired198;199;202;205) -... - December 06, 2007 - AnaSpec, EGT Group

Recent Headlines Within Biopharmaceuticals & Biotherapeutics

Recent Headlines
Within Biopharmaceuticals & Biotherapeutics